Delivery Order SPE2DB22D9207-SPE2DB25FH5FM
Award Date 9/23/25
Potential Completion Date 10/15/25
Potential Value $32K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On August 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $32,499.90 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge, IL. This award represents a firm fixed-price delivery order under the company's larger Indefinite Delivery Contract with the DLA, valued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,499.90 to DMS Pharmaceutical Group Inc. on August 26, 2025, for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with a firm fixed-price contract structure and ultimate completion date of September 17, 2025. The contract carries no set-aside designation, allowing the vendor to compete directly...
- The Defense Logistics Agency awarded a $32,499.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 29, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, represents a direct pharmaceutical supply fulfillment to support military healthcare operations. Performance is scheduled for completion by September 22, 2025, with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, with an ultimate completion date of October 1, 2025, represents a discrete purchase under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the vendor to compete on a full and open basis. DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, carries a firm fixed-price arrangement with no set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 22, 2025, for the supply of Stelara 90 mg/ml syringes. The award carries an ultimate completion date of August 12, 2025, and involves no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 30, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing the vendor to compete on an open basis despite its small...
- The Defense Logistics Agency (DLA) issued a delivery order valued at $32,499.90 to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was awarded on July 14, 2025, without a set-aside designation, leveraging the contractor's status as a woman-owned small business. The product will be delivered to Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters and primary operations....
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 15, 2025, for the supply of Stelara 90 mg/ml syringes. The award, which carries no set-aside designation, is scheduled for completion by October 6, 2025, with fulfillment to occur at the contractor's facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime contractor on this engagement. This...
- The Defense Logistics Agency (DLA) awarded a $16,249.95 delivery order to DMS Pharmaceutical Group Inc. on August 28, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price contract is set to conclude by September 19, 2025, with performance occurring at the vendor's location in Park Ridge, Illinois. The delivery order carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on the open market despite its status as a woman-owned small business. DMS...